Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 22, 2005
Functional characterization of three naturally occurring single nucleotide polymorphisms in the CES2 gene encoding carboxylesterase 2 (HCE-2)Takashi Kubo, Su-Ryang Kim, Kimie Sai, et al.
Pharmacogenetics and Genomics|June 15, 2007
Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28Hironobu Minami, Kimie Sai, Mayumi Saeki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 5, 2008
Close association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 haplotype and its apparent influence on 7-ethyl-10-hydroxycamptothecin (SN-38) glucuronidation in JapaneseYoshiro Saito, Kimie Sai, Keiko Maekawa, et al.
Drug Metabolism and Pharmacokinetics|November 19, 2010
Genetic polymorphisms and haplotypes of por, encoding cytochrome p450 oxidoreductase, in a Japanese populationYoshiro Saito, Noboru Yamamoto, Noriko Katori, et al.
Drug Metabolism and Pharmacokinetics|May 17, 2006
Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese populationKeiko Maekawa, Masaya Itoda, Kimie Sai, et al.
Cancer Chemotherapy and Pharmacology|November 10, 2007
Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patientsKimie Sai, Yoshiro Saito, Hiromi Fukushima-Uesaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 21, 2007
Haplotypes and a novel defective allele of CES2 found in a Japanese populationSu-Ryang Kim, Kimie Sai, Toshiko Tanaka-Kagawa, et al.
Pageof 7